title: A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.
abstract: Biomarkers are becoming increasingly more important in clinical decision-making, as well as basic science. Diagnosing myocardial infarction (MI) is largely driven by detecting cardiac-specific proteins in patients' serum or plasma as an indicator of myocardial injury. Having recently shown that cardiac myosin binding protein-C (cMyBP-C) is detectable in the serum after MI, we have proposed it as a potential biomarker for MI. Biomarkers are typically detected by traditional sandwich enzyme-linked immunosorbent assays. However, this technique requires a large sample volume, has a small dynamic range, and can measure only one protein at a time. Here we show a multiplex immunoassay in which three cardiac proteins can be measured simultaneously with high sensitivity. Measuring cMyBP-C in uniplex or together with creatine kinase MB and cardiac troponin I showed comparable sensitivity. This technique uses the Meso Scale Discovery (MSD) method of multiplexing in a 96-well plate combined with electrochemiluminescence for detection. While only small sample volumes are required, high sensitivity and a large dynamic range are achieved. Using this technique, we measured cMyBP-C, creatine kinase MB, and cardiac troponin I levels in serum samples from 16 subjects with MI and compared the results with 16 control subjects. We were able to detect all three markers in these samples and found all three biomarkers to be increased after MI. This technique is, therefore, suitable for the sensitive detection of cardiac biomarkers in serum samples.
authors: Department of Cell and Molecular Physiology, Loyola University Chicago, USA.
authors: Diederik W D
authors: DW
authors: Kuster
authors: David
authors: D
authors: Barefield
authors: Suresh
authors: S
authors: Govindan
authors: Sakthivel
authors: S
authors: Sadayappan
mesh_terms: D015415:Biomarkers / Q000097:blood; D002352:Carrier Proteins / Q000097:blood*; D016022:Case-Control Studies; D052279:Creatine Kinase, MB Form / Q000097:blood; D055664:Electrochemical Techniques / Q000379:methods; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008163:Luminescent Measurements / Q000379:methods; D009203:Myocardial Infarction / Q000097:blood*; D012680:Sensitivity and Specificity; D019210:Troponin I / Q000097:blood; D000099163:Myosin Binding Protein C
chemical_list: D015415:Biomarkers; D002352:Carrier Proteins; D052279:Creatine Kinase, MB Form; D019210:Troponin I; D000099163:Myosin Binding Protein C
references: J Muscle Res Cell Motil. 2012 May;33(1):43-52
references: 22127559
references: Methods. 2012 Apr;56(4):508-13
references: 22465283
references: J Mol Cell Cardiol. 2010 May;48(5):866-75
references: 19962384
references: J Mol Cell Cardiol. 2012 Jan;52(1):154-64
references: 21971072
references: Biophys Rev. 2012 Jun 1;4(2):93-106
references: 22707987
references: Clin Immunol. 2009 Nov;133(2):251-6
references: 19665935
references: Clin Vaccine Immunol. 2009 May;16(5):765-71
references: 19261777
references: Circulation. 2011 Nov 22;124(21):2350-4
references: 22105197
references: Biomark Med. 2012 Feb;6(1):69-72
references: 22296197
references: Nat Rev Drug Discov. 2006 Apr;5(4):310-20
references: 16582876
references: J Pharmacol Exp Ther. 2010 Aug;334(2):460-6
references: 20435921
references: J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):879-84
references: 18772478
references: Eur Heart J. 2012 Oct;33(20):2551-67
references: 22922414
references: Anal Chem. 2008 Jun 15;80(12):4741-51
references: 18484740
references: Clin Chem. 2010 Feb;56(2):314-8
references: 20022982